Skip to main content

Market Overview

Benzinga's M&A Chatter for Thursday August 6, 2015

Share:

The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday August 4, 2015:

IBM to Acquire Merge Healthcare for $7.13/Share in Cash

The Deal:
IBM (NYSE: IBM) announced Thursday, that it plans to acquire Merge Healthcare (NASDAQ: MRGE) for 7.13 per share in cash, for a total transaction value of $1 billion. The deal is expected to close later this year.

Merge closed at $7.10 on Thursday, a gain of 31%.

Mesa Labs Acquires Dental Sterilizer Testing Business for $11.25M

The Deal:
Mesa Laboratories, Inc. (NASDAQ: MLAB) announced Thursday, the acquisition of substantially all of the assets and certain liabilities of the dental sterilizer testing business of North Bay Bioscience, LLC. for $11,250,000 in cash.

Mesa Labs closed at $119.57 Thursday, a gain of 1%.

Coca-Cola Enterprises Merges With Coca-Cola Iberian Partners, Coca-Cola Erfrischungsgetränke AG

The Deal:
Coca-Cola Enterprises, Inc. (NYSE: CCE), Coca-Cola Iberian Partners SA and Coca-Cola Erfrischungsgetränke AG , a wholly owned subsidiary of The Coca-Cola Company (NYSE: KO), announced Thursday, that they have agreed to combine their businesses into a new company to be called Coca-Cola European Partners Plc. The new company will become the world's largest independent Coca-Cola bottler based on net revenues.

Coca-Cola Enterprises closed at $53.39 Thursday, a gain of almost 3%.

 

Related Articles (CCE + IBM)

View Comments and Join the Discussion!

Posted-In: M&A News Rumors Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com